Explore / Peer-reviewed article
Peer-reviewed article

Targeting the 5-HT<sub>2A</sub> Receptor for Developing Psychedelic Drugs and Beyond.

Ali SiD, Tian XiD, Cunningham KAiD, Zhou JiD

Journal of medicinal chemistryMay 1, 2025United States8 citationsDOI: 10.1021/acs.jmedchem.5c01156

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psychedelics
View paperFull text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsychedelics

Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness.

Lehrner A, Hildebrandt TB, Yehuda R

Europe PMC2025
ArticlePsychedelics

AbbVie bets on psychedelic drugs in Gilgamesh buy out.

Mullard A

Europe PMC2025
ArticlePsychedelics

Taking the tripping out of psychedelic medicine.

Dolgin E

Europe PMC2022